Structures by: Narayana B.
Total: 474
(2E)-3-(4-Chlorophenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one
C15H11ClO2
Acta Crystallographica Section E (2007) 63, 8 o3661-o3661
a=7.5910(7)Å b=10.8509(7)Å c=15.1544(11)Å
α=90.00° β=104.213(8)° γ=90.00°
7-Hydroxy-4-methyl-2<i>H</i>-chromen-2-one monohydrate
C10H8O3,H2O
Acta Crystallographica Section E (2007) 63, 8 o3412-o3413
a=6.9508(5)Å b=11.3074(8)Å c=11.7833(8)Å
α=90.00° β=105.6430(10)° γ=90.00°
2,4-Diacetylquinoline
C13H11NO2
Acta Crystallographica Section E (2007) 63, 8 o3557-o3557
a=7.5285(6)Å b=15.0366(12)Å c=9.7202(7)Å
α=90.00° β=105.704(9)° γ=90.00°
(2E)-3-(4-Fluorophenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one
C15H11FO2
Acta Crystallographica Section E (2007) 63, 8 o3586-o3586
a=7.4149(4)Å b=11.3162(6)Å c=14.7472(8)Å
α=90.00° β=104.311(6)° γ=90.00°
1-(Quinolin-2-yl)ethanone
C11H9NO
Acta Crystallographica Section E (2007) 63, 8 o3603-o3603
a=10.3292(4)Å b=24.1165(9)Å c=15.0923(5)Å
α=90.00° β=109.7820(10)° γ=90.00°
Β-Arteether
C17H28O5
Acta Crystallographica Section E (2008) 64, 3 o585-o586
a=10.0253(6)Å b=10.0253(6)Å c=28.628(3)Å
α=90.00° β=90.00° γ=120.00°
<i>rac</i>-Ethyl 3-(3-bromo-2-thienyl)-2-oxo-6-(4-propoxyphenyl)cyclohex-3-ene-1-carboxylate
C22H23BrO4S
Acta Crystallographica Section E (2008) 64, 11 o2152
a=8.809(3)Å b=11.878(2)Å c=20.178(7)Å
α=92.66(2)° β=94.61(2)° γ=90.16(2)°
(5<i>RS</i>,6<i>SR</i>)-6-(4-Fluorobenzoyl)-5-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5,6-dihydro-4<i>H</i>-1,3,4-oxadiazine <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C22H16F2N2O3,C3H7NO
Acta Crystallographica Section C (2014) 70, 9
a=17.5182(7)Å b=7.4306(3)Å c=17.5595(7)Å
α=90° β=101.252(4)° γ=90°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)-3,5-Bis(4-fluorophenyl)-2,4-bis(pyridine-2-carbonyl)1-(pyridin-2-yl)cyclohexanol
C35H27F2N3O3
Acta Crystallographica Section C (2014) 70, 10 953-959
a=21.8864(9)Å b=11.2268(4)Å c=24.2670(9)Å
α=90° β=90° γ=90°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)- 3,5-Bis(4-bromophenyl)-2,4-bis(pyridine-2-carbonyl)-1-(pyridin-2-yl)cyclohexanol
C35H27Br2N3O3
Acta Crystallographica Section C (2014) 70, 10 953-959
a=9.5741(4)Å b=10.7061(3)Å c=15.9952(6)Å
α=92.863(3)° β=97.443(3)° γ=103.618(3)°
(1<i>RS</i>,2<i>SR</i>,3<i>SR</i>,4<i>RS</i>,5<i>RS</i>)-3,5-Bis(4-chlorophenyl)-2,4-bis(pyridine-2-carbonyl)-1-(pyridin-2-yl)cyclohexanol acetone 0.951-solvate
C35H27Cl2N3O3,0.951(C3H6O)
Acta Crystallographica Section C (2014) 70, 10 953-959
a=16.5446(6)Å b=53.4204(17)Å c=15.5857(4)Å
α=90° β=90° γ=90°
(2<i>E</i>)-3-(6-Methoxynaphthalen-2-yl)-1-(pyridin-3-yl)prop-2-en-1-one
C19H15NO2
Acta Crystallographica Section C (2014) 70, 11 1011-1016
a=14.2636(6)Å b=16.6789(6)Å c=6.0084(2)Å
α=90° β=90° γ=90°
(<i>RS</i>)-2-Amino-4-(6-methoxynaphthalen-2-yl)-6-(pyridin-3-yl)-3,4-dihydropyrimidine monohydrate
C20H18N4O,H2O
Acta Crystallographica Section C (2014) 70, 11 1011-1016
a=17.2244(5)Å b=5.9552(2)Å c=18.5173(6)Å
α=90° β=112.8300(10)° γ=90°
(2<i>E</i>)-1-(2,4-Dichlorophenyl)-3-[4-(prop-1-en-2-yl)phenyl]prop-2-en-1-one
C18H14Cl2O
Acta Crystallographica Section C (2015) 71, 7
a=13.4314(4)Å b=8.2405(4)Å c=29.9252(9)Å
α=90° β=90° γ=90°
(5<i>RS</i>)-3-(4-Chlorophenyl)-5-[4-(propan-2-yl)phenyl]cyclohex-2-en-1-one
C21H21ClO
Acta Crystallographica Section C (2015) 71, 7
a=6.6259(8)Å b=8.6868(11)Å c=30.472(4)Å
α=90° β=91.765(4)° γ=90°
2,3-dibromo-1,3-diphenylpropan-1-one
C15H12Br2O
Acta Crystallographica Section C (2005) 61, 12 o728-o730
a=20.6762(7)Å b=7.2443(2)Å c=10.3501(3)Å
α=90.00° β=116.575(2)° γ=90.00°
(+-)-Ethyl 6-(6-methoxy-2-naphthyl)-4-(4-methylphenyl)-2-oxocyclohex-3-ene-1-carboxylate
C27H26O4
Acta Crystallographica Section E (2009) 65, 6 o1186
a=18.8013(10)Å b=11.3604(6)Å c=10.2356(6)Å
α=90.00° β=93.430(2)° γ=90.00°
(E)-3-(4-Bromophenyl)-1-(3,4-dichlorophenyl)prop-2-en-1-one
C15H9BrCl2O
Acta Crystallographica Section E (2009) 65, 4 o836
a=5.9370(5)Å b=7.7365(6)Å c=14.8254(11)Å
α=81.347(6)° β=88.182(6)° γ=88.315(6)°
4-(4-Carboxybenzyl)-1-methylpiperazin-1-ium picrate
C13H19N2O2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 3 o518
a=7.3020(12)Å b=9.5993(16)Å c=15.131(3)Å
α=86.448(2)° β=79.145(2)° γ=79.950(2)°
2-Bromo-<i>N</i>'-[(2<i>Z</i>)-butan-2-ylidene]-5-methoxybenzohydrazide
C12H15BrN2O2
Acta Crystallographica Section E (2009) 65, 11 o2968-o2969
a=8.09420(10)Å b=14.2475(2)Å c=11.2974(2)Å
α=90.00° β=91.1519(13)° γ=90.00°
3-(2-Chloroethyl)-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-4-one
C11H11ClN2O
Acta Crystallographica Section E (2009) 65, 8 o1987-o1988
a=4.2546(4)Å b=11.6274(10)Å c=20.604(2)Å
α=90.00° β=90.00° γ=90.00°
2-Bromo-N'-[(Z)-2-bromobenzylidene]-5-methoxybenzohydrazide
C15H12Br2N2O2
Acta Crystallographica Section E (2009) 65, 8 o1750
a=14.768(5)Å b=12.753(4)Å c=8.227(3)Å
α=90.00° β=96.114(4)° γ=90.00°
(2<i>E</i>)-3-(3-Bromophenyl)-1-(4-chlorophenyl)prop-2-en-1-one
C15H10BrClO
Acta Crystallographica Section E (2009) 65, 8 o1915
a=14.7421(10)Å b=6.1024(4)Å c=15.1874(10)Å
α=90.00° β=103.905(2)° γ=90.00°
(2<i>E</i>)-1-(4-fluorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C18H17FO4
Acta Crystallographica Section E (2009) 65, 8 o1965-o1966
a=12.4250(2)Å b=8.62800(10)Å c=14.9038(2)Å
α=90.00° β=98.3217(12)° γ=90.00°
6-{[(Benzyloxy)carbonyl]oxy}-2-methylhexahydropyrano[3,2-<i>d</i>][1,3]dioxin-7,8-diyl bis(chloroacetate)
C20H22Cl2O10
Acta Crystallographica Section E (2010) 66, 3 o572-o573
a=8.17800(10)Å b=14.9165(3)Å c=19.3555(4)Å
α=90.00° β=90.00° γ=90.00°
Orphenadrinium picrate picric acid
C18H24NO,C6H2N3O7,C6H3N3O7
Acta Crystallographica Section E (2010) 66, 3 o682-o683
a=11.1914(9)Å b=12.4481(10)Å c=22.6127(19)Å
α=90.00° β=93.6010(10)° γ=90.00°
Bis[4-(4-chlorophenyl)-4-hydroxypiperidinium] dipicrate dimethyl sulfoxide solvate
2(C11H15ClNO),2(C6H2N3O7),C2H6OS
Acta Crystallographica Section E (2010) 66, 5 o1212-o1213
a=8.9207(4)Å b=18.1230(9)Å c=12.9886(6)Å
α=90.00° β=98.4300(10)° γ=90.00°
Lansoprazole intermediate--chloranilic acid (2:1)
2(C16H15F3N3OS),C6Cl2O42
Acta Crystallographica Section E (2010) 66, 6 o1507-o1508
a=9.48575(8)Å b=23.6316(2)Å c=17.86775(15)Å
α=90.00° β=100.2065(9)° γ=90.00°
3,5-Bis(4-bromophenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C21H16Br2N2
Acta Crystallographica Section E (2010) 66, 6 o1279-o1280
a=10.5815(3)Å b=11.2119(3)Å c=15.4569(4)Å
α=90° β=90° γ=90°
2-(4-Chlorophenyl)-6-methoxychroman-4-one
C16H13ClO3
Acta Crystallographica Section E (2010) 66, 10 o2546-o2547
a=5.0188(3)Å b=12.0138(7)Å c=12.3708(7)Å
α=108.035(5)° β=98.379(4)° γ=91.820(5)°
Fluconazolium picrate
C13H13F2N6O,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 10 o2568
a=5.6470(10)Å b=17.347(2)Å c=22.571(2)Å
α=90.00° β=94.270(10)° γ=90.00°
(2<i>E</i>)-3-{4-[(1<i>H</i>-1,3-Benzimidazol-2-yl)methoxy]-3-ethoxyphenyl}- 1-(4-bromophenyl)prop-2-en-1-one monohydrate
C25H21BrN2O3,H2O
Acta Crystallographica Section E (2011) 67, 4 o834-o835
a=13.8406(12)Å b=16.5192(8)Å c=19.4719(13)Å
α=90.00° β=90.00° γ=90.00°
3,5-Bis(4-methylphenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C23H22N2
Acta Crystallographica Section E (2011) 67, 4 o1019
a=5.8113(3)Å b=10.6959(5)Å c=28.4455(13)Å
α=90° β=94.983(4)° γ=90°
1-(2,5-Dichloro-3-thienyl)ethanone
C6H4Cl2OS
Acta Crystallographica Section E (2010) 66, 10 o2480
a=13.0980(3)Å b=7.17900(10)Å c=16.3290(3)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-3-(4-Chlorophenyl)-1-(1-naphthyl)prop-2-en-1-one
C19H13ClO
Acta Crystallographica Section E (2009) 65, 12 o3255-o3256
a=12.0392(14)Å b=8.0544(5)Å c=7.8472(6)Å
α=90.00° β=98.091(10)° γ=90.00°
<i>N</i>,<i>N</i>'-Bis[(<i>E</i>)-2-fluorobenzylidene]-1-(2- fluorophenyl)methanediamine
C21H15F3N2
Acta Crystallographica Section E (2010) 66, 2 o422-o423
a=8.0215(5)Å b=9.3740(4)Å c=11.9744(6)Å
α=99.184(4)° β=93.179(5)° γ=108.165(5)°
Chloranilic acid
C6H2Cl2O4
Acta Crystallographica Section E (2010) 66, 2 o497-o498
a=7.5338(12)Å b=5.5225(10)Å c=8.5720(12)Å
α=90.00° β=104.868(11)° γ=90.00°
4-(Methylsulfonyl)piperazin-1-ium chloride
C5H13N2O2S,Cl
Acta Crystallographica Section E (2010) 66, 2 o361-o362
a=6.02310(10)Å b=9.1097(2)Å c=7.9852(2)Å
α=90.00° β=100.7000(10)° γ=90.00°
2,4-Dichloro-1-[1-(2,4-dichlorobenzyloxy)ethyl]benzene
C15H12Cl4O
Acta Crystallographica Section E (2010) 66, 1 o165-o166
a=9.3755(4)Å b=9.9229(4)Å c=9.9667(4)Å
α=62.313(3)° β=70.246(4)° γ=71.467(4)°
Pefloxacinium picrate
C17H21FN3O3,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 3 o714-o715
a=7.26450(10)Å b=9.1987(2)Å c=20.2253(4)Å
α=77.1160(10)° β=81.3150(10)° γ=67.1240(10)°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(4-bromophenyl)prop-2-en-1-one
C15H10Br2O
Acta Crystallographica Section E (2010) 66, 7 o1701
a=5.6988(5)Å b=9.5462(9)Å c=23.8532(15)Å
α=90.00° β=91.021(8)° γ=90.00°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C18H17BrO4
Acta Crystallographica Section E (2010) 66, 7 o1676
a=9.9616(4)Å b=13.6020(13)Å c=24.4162(17)Å
α=90.00° β=90.00° γ=90.00°
(1<i>RS</i>,6<i>SR</i>)-Ethyl 4,6-bis(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C21H18F2O3
Acta Crystallographica Section E (2011) 67, 2 o336
a=11.062(2)Å b=11.675(3)Å c=13.854(3)Å
α=90.00° β=92.89(2)° γ=90.00°
(1<i>RS</i>,6<i>SR</i>)-Ethyl 4-(2,4-dichlorophenyl)-6-(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C21H17Cl2FO3
Acta Crystallographica Section E (2011) 67, 2 o445-o446
a=32.321(5)Å b=5.437(2)Å c=22.309(3)Å
α=90.00° β=90.00° γ=90.00°
1-methylpiperazine-1,4-diium dipicrate
C5H14N22,2(C6H2N3O7)
Acta Crystallographica Section E (2011) 67, 2 o390-o391
a=8.2001(12)Å b=10.1780(15)Å c=13.7399(18)Å
α=89.798(12)° β=78.130(11)° γ=81.558(12)°
(1<i>RS</i>,6<i>SR</i>)-Ethyl 4-(4-chlorophenyl)-6-(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate toluene hemisolvate
C21H18ClFO3,0.5(C7H8)
Acta Crystallographica Section E (2011) 67, 2 o334-o335
a=7.572(2)Å b=11.259(3)Å c=13.362(3)Å
α=69.42(2)° β=86.58(2)° γ=70.98(2)°
Ethylenediammonium dipicrate dihydrate
C2H10N22,2(C6H2N3O7),2(H2O)
Acta Crystallographica Section E (2011) 67, 3 o637-o638
a=13.4795(4)Å b=20.4372(7)Å c=8.0410(3)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-1-(1,3-Benzodioxol-5-yl)-3-(3-bromophenyl)prop-2-en-1-one
C16H11BrO3
Acta Crystallographica Section E (2008) 64, 12 o2387
a=14.237(3)Å b=8.1811(17)Å c=11.717(2)Å
α=90.00° β=100.658(3)° γ=90.00°
Gabapentinium picrate
C9H18NO2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 4 o783
a=11.576(2)Å b=7.7312(16)Å c=19.973(4)Å
α=90.00° β=91.425(2)° γ=90.00°
Ethyl 6-(6-methoxy-2-naphthyl)-2-oxo-4-(2-thienyl)cyclohex-3-ene-1-carboxylate
C24H22O4S
Acta Crystallographica Section E (2009) 65, 7 o1533
a=18.2501(4)Å b=11.7176(2)Å c=9.6846(2)Å
α=90.00° β=93.0480(10)° γ=90.00°
4-(2,2-Diphenyl-2-propoxyacetoxy)-1-methylpiperidin-1-ium picrate
C23H30NO3,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 8 o1738-o1739
a=8.9379(4)Å b=9.2885(4)Å c=18.0750(7)Å
α=97.652(3)° β=97.630(3)° γ=104.301(4)°
3-(2-Chloroethyl)-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>] pyrimidinium-4-one picrate
C11H12ClN2O,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 9 o2201-o2202
a=7.2718(5)Å b=12.8159(9)Å c=19.940(3)Å
α=90.00° β=97.642(9)° γ=90.00°
Haloperidol picrate
C21H24ClFNO2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 10 o2403-o2404
a=14.9089(5)Å b=12.5934(3)Å c=14.5074(5)Å
α=90.00° β=90.00° γ=90.00°
4-(2-Chloroethyl)morpholinium picrate
C6H13ClNO,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 10 o2435
a=8.2063(4)Å b=9.3075(5)Å c=10.2896(6)Å
α=93.954(5)° β=95.284(5)° γ=90.376(4)°
2-Bromo-1,3-bis(4-chlorophenyl)prop-2-en-1-one
C15H9BrCl2O
Acta Crystallographica Section E (2009) 65, 11 o2648
a=7.7416(3)Å b=9.7981(4)Å c=9.6717(3)Å
α=90.00° β=109.075(2)° γ=90.00°
(<i>E</i>)-3-(Biphenyl-4-yl)-1-(3-bromophenyl)prop-2-en-1-one
C21H15BrO
Acta Crystallographica Section E (2009) 65, 11 o2856-o2857
a=6.0920(10)Å b=7.2950(10)Å c=36.619(2)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-1-(3-Chlorophenyl)-3-(4-chlorophenyl)prop-2-en-1-one
C15H10Cl2O
Acta Crystallographica Section E (2009) 65, 11 o2641-o2642
a=5.8884(9)Å b=7.3328(9)Å c=14.6752(16)Å
α=102.821(10)° β=95.003(10)° γ=92.933(11)°
2-(4-Chlorophenoxy)acetohydrazide
C8H9ClN2O2
Acta Crystallographica Section E (2009) 65, 12 o3189
a=6.4440(10)Å b=4.0110(10)Å c=35.369(4)Å
α=90.00° β=91.890(10)° γ=90.00°
(2<i>E</i>)-3-(4-Bromophenyl)-1-(3-chlorophenyl)prop-2-en-1-one
C15H10BrClO
Acta Crystallographica Section E (2010) 66, 1 o158
a=5.9197(8)Å b=7.3391(11)Å c=14.8171(17)Å
α=101.929(11)° β=94.371(10)° γ=93.299(11)°
6,11-Dihydrodibenz[<i>b</i>,<i>e</i>]oxepin-11-one
C14H10O2
Acta Crystallographica Section E (2010) 66, 1 o159-o160
a=16.5065(18)Å b=4.0806(7)Å c=15.0392(17)Å
α=90.00° β=93.654(10)° γ=90.00°
Gabapentin-lactum--chloranilic acid (1/1)
C9H15NO,C6H2Cl2O4
Acta Crystallographica Section E (2010) 66, 1 o163-o164
a=6.6127(9)Å b=9.5800(11)Å c=13.0724(13)Å
α=102.679(9)° β=91.934(9)° γ=98.481(10)°
(2<i>E</i>)-1-(3-Chlorophenyl)-3-phenylprop-2-en-1-one
C15H11ClO
Acta Crystallographica Section E (2010) 66, 1 o157
a=5.8388(7)Å b=7.5975(11)Å c=13.1300(16)Å
α=83.182(11)° β=89.422(10)° γ=86.662(11)°
Dibenzo[<i>b</i>,<i>e</i>]thiepin-11(6<i>H</i>)-one
C14H10OS
Acta Crystallographica Section E (2010) 66, 2 o350
a=14.6208(11)Å b=4.3503(3)Å c=16.9023(13)Å
α=90.00° β=90.00° γ=90.00°
Chlorimipraminium picrate
C19H24ClN2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 2 o347-o348
a=11.2252(3)Å b=13.1514(3)Å c=17.2787(4)Å
α=90.9414(19)° β=91.1253(19)° γ=100.4446(19)°
Imatinibium dipicrate
C29H33N7O2,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 2 o411-o412
a=8.560000Å b=10.734000Å c=23.060000Å
α=96.74(3)° β=92.69(2)° γ=101.46(7)°
1-(1,3-Benzodioxol-5-yl)ethanone
C9H8O3
Acta Crystallographica Section E (2010) 66, 2 o383
a=9.4697(3)Å b=10.8445(3)Å c=7.5148(3)Å
α=90.00° β=105.973(3)° γ=90.00°
2-Chloro-<i>N</i>-[4-chloro-2-(2-chlorobenzoyl)phenyl]acetamide
C15H10Cl3NO2
Acta Crystallographica Section E (2010) 66, 2 o499
a=7.5776(9)Å b=10.1565(10)Å c=10.7862(12)Å
α=70.069(8)° β=77.604(9)° γ=70.388(8)°
4-Amino-<i>N</i>-(6-chloro-5-methoxypyrimidin-4-yl)benzenesulfonamide
C11H11ClN4O3S
Acta Crystallographica Section E (2010) 66, 2 o372-o373
a=12.8792(6)Å b=13.3557(6)Å c=8.0867(4)Å
α=90.00° β=102.3960(10)° γ=90.00°
1-(4-chlorophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
C16H13ClO2
Acta Crystallographica Section E (2010) 66, 2 o269-o270
a=15.6695(7)Å b=14.1235(8)Å c=5.8455(3)Å
α=90.00° β=90.771(5)° γ=90.00°
<i>N</i>-(5-Amino-2-methylphenyl)-4-(3-pyridyl)pyrimidin-2-amine
C16H15N5
Acta Crystallographica Section E (2010) 66, 2 o349
a=9.2242(3)Å b=12.5399(4)Å c=12.8594(4)Å
α=72.719(3)° β=89.724(3)° γ=77.712(3)°
3-(10,11-dihydro-5<i>H</i>-dibenzo[<i>b</i>,<i>f</i>]azepin-5-yl)- <i>N</i>,<i>N</i>,2-trimethylpropan-1-aminium hydrogen maleate
C20H27N2,C4H3O4
Acta Crystallographica Section E (2010) 66, 2 o366-o367
a=19.4356(4)Å b=11.0542(4)Å c=40.4107(13)Å
α=90.00° β=90.00° γ=90.00°
1-[3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]ethanone
C17H14F2N2O
Acta Crystallographica Section E (2010) 66, 3 o582-o583
a=7.14470(10)Å b=17.2332(3)Å c=18.4871(4)Å
α=102.8800(10)° β=97.9410(10)° γ=96.3730(10)°
(<i>E</i>)-1-(4-Methylphenyl)ethanone [8-(trifluoromethyl)quinolin-4-yl]hydrazone
C19H16F3N3
Acta Crystallographica Section E (2010) 66, 4 o874
a=8.2811(9)Å b=14.8443(15)Å c=13.5325(15)Å
α=90.00° β=90.601(9)° γ=90.00°
3-(3-Bromo-4-methoxyphenyl)-1,5-diphenylpentane-1,5-dione
C24H21BrO3
Acta Crystallographica Section E (2010) 66, 4 o816
a=12.7305(4)Å b=7.14024(19)Å c=22.8133(8)Å
α=90.00° β=105.602(3)° γ=90.00°
Methyl 4,6-bis(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C20H16F2O3
Acta Crystallographica Section E (2010) 66, 4 o864-o865
a=17.3774(5)Å b=9.0629(3)Å c=22.2238(7)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-methoxy-6-methylpyrimidin-1-ium picrate
C6H10N3O,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 5 o1189-o1190
a=8.9442(3)Å b=6.2793(3)Å c=27.0354(8)Å
α=90.00° β=94.471(3)° γ=90.00°
2-(4-Methoxyphenyl)-6-trifluoromethyl-1<i>H</i>-pyrrolo[3,2-<i>c</i>]quinoline monohydrate
C19H13F3N2O,H2O
Acta Crystallographica Section E (2010) 66, 5 o1111-o1112
a=13.8380(10)Å b=7.0432(5)Å c=17.758(2)Å
α=90.00° β=102.743(8)° γ=90.00°
(<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-[4-(dimethylamino)phenyl]prop-2-en-1-one
C15H13Cl2NOS
Acta Crystallographica Section E (2010) 66, 5 o1139
a=7.2637(9)Å b=8.1136(9)Å c=13.478(2)Å
α=89.011(9)° β=79.710(10)° γ=73.070(10)°
(2<i>E</i>)-1-(4-Bromophenyl)-3-(4-fluorophenyl)prop-2-en-1-one
C15H10BrFO
Acta Crystallographica Section E (2010) 66, 5 o1243-o1244
a=4.0060(5)Å b=23.1253(12)Å c=13.4933(9)Å
α=90.00° β=96.344(6)° γ=90.00°
5,7-Dimethyl-2,3-dihydro-1<i>H</i>-1,4-diazepin-4-ium picrate
C7H13N2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 5 o1187-o1188
a=7.2341(3)Å b=27.6458(6)Å c=8.2831(3)Å
α=90.00° β=110.611(4)° γ=90.00°
5α-androstane-3,17-dione
C19H28O2
Acta Crystallographica Section E (2010) 66, 6 o1517-o1518
a=12.7786(6)Å b=6.7850(4)Å c=19.6242(10)Å
α=90.00° β=106.444(5)° γ=90.00°
(2<i>E</i>)-1-(1,3-Benzodioxol-5-yl)-3-(2-bromophenyl)prop-2-en-1-one
C16H11BrO3
Acta Crystallographica Section E (2010) 66, 6 o1289-o1290
a=5.0434(2)Å b=12.9354(4)Å c=20.8916(7)Å
α=90.00° β=90.00° γ=90.00°
(2E)-1-(2-Bromophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
C16H13BrO2
Acta Crystallographica Section E (2010) 66, 7 o1661
a=12.7300(8)Å b=4.0061(3)Å c=13.0035(6)Å
α=90.00° β=100.671(5)° γ=90.00°
(2<i>E</i>)-1-(2-Bromophenyl)-3-(4-chlorophenyl)prop-2-en-1-one
C15H10BrClO
Acta Crystallographica Section E (2010) 66, 7 o1638
a=5.7317(6)Å b=9.3920(7)Å c=23.6517(18)Å
α=90.00° β=91.231(8)° γ=90.00°
(<i>E</i>)-1-(4-Bromophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one
C16H13BrO2
Acta Crystallographica Section E (2010) 66, 8 o1995
a=17.729(4)Å b=4.3505(9)Å c=19.335(4)Å
α=90.00° β=116.93(3)° γ=90.00°
(<i>E</i>)-1-(2-Bromophenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one
C17H15BrO3
Acta Crystallographica Section E (2010) 66, 8 o1952
a=7.7643(9)Å b=9.7006(11)Å c=10.2722(10)Å
α=72.901(10)° β=78.487(9)° γ=86.359(9)°
1-[3,5-Bis(4-chlorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]ethanone
C17H14Cl2N2O
Acta Crystallographica Section E (2010) 66, 8 o1950-o1951
a=6.0716(9)Å b=13.160(2)Å c=19.782(3)Å
α=90.00° β=98.412(2)° γ=90.00°
4-(1<i>H</i>-Benzimidazol-2-ylmethoxy)-3-ethoxybenzaldehyde trihydrate
C17H16N2O3,3(H2O)
Acta Crystallographica Section E (2010) 66, 8 o2052
a=7.3020(15)Å b=9.3170(19)Å c=25.950(5)Å
α=90.00° β=90.00° γ=90.00°
(2-Methylphenyl)(phenyl)methanol
C14H14O
Acta Crystallographica Section E (2010) 66, 8 o2136
a=23.013(2)Å b=23.013Å c=10.6067(11)Å
α=90° β=90° γ=120°
(<i>E</i>)-3-(4-Methoxyphenyl)-1-[4-(piperidin-1-yl)phenyl]prop-2-en-1-one
C21H23NO2
Acta Crystallographica Section E (2010) 66, 8 o1996
a=6.0963(11)Å b=10.985(2)Å c=13.133(3)Å
α=74.188(3)° β=88.674(3)° γ=77.393(3)°
3,5-Bis(4-fluorophenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C21H16F2N2
Acta Crystallographica Section E (2010) 66, 8 o1948-o1949
a=12.2880(3)Å b=13.1678(3)Å c=11.3245(3)Å
α=90.00° β=112.661(3)° γ=90.00°
8-Bromo-1,3-diphenyl-2,3-dihydro-1<i>H</i>-naphtho[1,2-<i>e</i>][1,3]oxazine
C24H18BrNO
Acta Crystallographica Section E (2010) 66, 8 o2053-o2054
a=7.7617(11)Å b=20.092(3)Å c=11.5094(16)Å
α=90.00° β=91.893(2)° γ=90.00°
2,3-Dibromo-1,3-bis(4-fluorophenyl)propan-1-one
C15H10Br2F2O
Acta Crystallographica Section E (2010) 66, 8 o2018
a=5.7381(13)Å b=9.909(2)Å c=12.575(3)Å
α=75.324(3)° β=87.472(3)° γ=82.300(3)°
4-(4-Chlorophenyl)-4-hydroxypiperidinium maleate maleic acid solvate
C11H15ClNO,C4H3O4,C4H4O4
Acta Crystallographica Section E (2010) 66, 8 o2012-o2013
a=19.282(7)Å b=7.867(3)Å c=25.115(9)Å
α=90.00° β=91.545(5)° γ=90.00°
Opipramol dipicrate
C23H31N3O2,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 8 o1979-o1980
a=7.3838(8)Å b=12.0400(13)Å c=22.074(2)Å
α=74.8210(10)° β=84.355(2)° γ=73.866(2)°
(<i>E</i>)-1-(2,5-Dichloro-3-thienyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one
C15H12Cl2O3S
Acta Crystallographica Section E (2010) 66, 10 o2479
a=8.9331(2)Å b=8.9997(2)Å c=18.8210(5)Å
α=90.00° β=100.1810(10)° γ=90.00°
(2<i>E</i>)-3-(1,3-Benzodioxol-5-yl)-1-(3-bromo-2-thienyl)prop-2-en-1-one
C14H9BrO3S
Acta Crystallographica Section E (2010) 66, 10 o2477
a=4.0013(3)Å b=11.0211(9)Å c=14.6931(11)Å
α=90.00° β=95.781(2)° γ=90.00°
(2<i>E</i>)-1-(3-Bromophenyl)-3-(6-methoxy-2-naphthyl)prop-2-en-1-one
C20H15BrO2
Acta Crystallographica Section E (2010) 66, 10 o2552
a=14.0955(14)Å b=6.1295(6)Å c=36.119(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(2,4-dichlorophenyl)-6-(6-methoxy-2-naphthyl)-2-oxocyclohex-3-ene- 1-carboxylate
C26H22Cl2O4
Acta Crystallographica Section E (2010) 66, 10 o2478
a=14.2156(4)Å b=5.8647(2)Å c=27.3752(9)Å
α=90.00° β=94.840(2)° γ=90.00°
Orphenadrinium picrate
C18H24NO,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o190-o191
a=9.9434(10)Å b=11.2216(8)Å c=11.3523(12)Å
α=78.658(7)° β=76.342(9)° γ=87.660(7)°